A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer

Biomedicine and Pharmacotherapy

Volumn 66, Issue 1, 2012, Pages 21-28

  Gao, W ^a   Xu, J ^a   Liu, L ^a   Shen, H ^a   Zeng, H ^b   Shu, Y ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Shanghai Sensichip Infotech CoLtd   (China)

Author keywords

Lung cancer; MiR 21; Systematic analysis

Indexed keywords

MICRORNA 21;

ARTICLE; COMPUTATIONAL FLUID DYNAMICS; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; LUNG CANCER; PREDICTION; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

APOPTOSIS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84862776527     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.09.004     Document Type: Article

References (25)

1. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866.
2. Gao W., Shen H., Liu L., Xu J., Shu Y. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Onco 2011, 137:557-566.
3. Krichevsky A.M., Gabriely G. MiR-21: a small multi-faceted RNA. J Cell Mol Med 2009, 13(1):39-53.
4. Settles B. ABNER: an open source tool for automatically tagging genes, proteins and other entity names in text. Bioinformatics 2005, 21:3191-3192.
5. Smith L., Tanabe L.K., Ando R.J., Kuo C.J., Chung I.F., Hsu C.N., et al. Overview of BioCreative II gene mention recognition. Genome Biol 2008, 9:S2.
6. Morgan A.A., Lu Z., Wang X., Cohen A.M., Fluck J., Ruch P., et al. Overview of BioCreative II gene normalization. Genome Biol 2008, 9(Suppl. 2):S3.
7. Morgan M, Falcon S, Gentleman R. GSEABase: gene set enrichment data structures and methods. R package version 1.4.0.
8. Dahlquist K.D., Salomonis N., Vranizan K., Lawlor S.C., Conklin B.R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002, 31:19-20.
9. Ogata H., Goto S., Fujibuchi W., Kanehisa M. Computation with the KEGG pathway database. Biosystems 1998, 47:119-128.
10. Mewes H.W., Albermann K., Heumann K., Liebl S., Pfeiffer F. MIPS: a database for protein sequences, homology data and yeast genome information. Nucleic Acids Res 1997, 25:28-30.
11. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
12. Mitsudomi T., Hamajima N., Ogawa M., Takahashi T. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 2000, 6:4055-4063.
13. Singhal S., Vachani A., Antin-Ozerkis D., Kaiser L.R., Albelda S.M. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 2005, 11:3974-3986.
14. Dhillon A.S., Hagan S., Rath O., Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007, 26:3279-3290.
15. Wu C., Wangpaichitr M., Feun L., Kuo M.T., Robles C., Lampidis T., et al. Overcoming cisplatin resistance by mTOR inhibitor in lung cancer. Mol Cancer 2005, 4:25.
16. Tong A.H., Lesage G., Bader G.D., Ding H., Xu H., Xin X., et al. Global mapping of the yeast genetic interaction network. Science 2004, 303:808-813.
17. Endoh H., Yatabe Y., Kosaka T., Kuwano H., Mitsudomi T. PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients. J Thorac Oncol 2006, 1:629-634.
18. Yun H.J., Kim S.Y., Kwon Y.Y., Kim C.H., Kang C.M., Kim E.J. Janus-activated kinases and signal transducer and activator of transcription control tumor growth response to camptothecin in human colon cancer cells. Cancer Biol Ther 2010, 10:354-361.
19. Bierie B., Moses H.L. TGF-beta and cancer. Cytokine Growth Factor Rev 2006, 17:29-40.
20. Keshamouni V.G., Reddy R.C., Arenberg D.A., Joel B., Thannickal V.J., Kalemkerian G.P., et al. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer. Oncogene 2004, 23:100-108.
21. Sriuranpong V., Borges M.W., Ravi R.K., Arnold D.R., Nelkin B.D., Baylin S.B. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 2001, 61:3200-3205.
22. Uematsu K., He B., You L., Xu Z., McCormick F., Jablons D.M. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003, 16:7218-7221.
23. Ejendal K.F., Hrycyna C.A. Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Curr Protein Pept Sci 2002, 3:503-511.
24. Cheng L., Spitz M.R., Hong W.K., Wei Q. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis 2000, 21:1527-1530.
25. Meng F., Henson R., Wehbe-Janek H. MiRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.